Filings monitor · CAH

What CARDINAL HEALTH INC's SEC filings said

10-Q for 2026Q3, filed 5 Nov 2026, and 1 8-K since. Each line is something a filing stated, ranked by score and linked to its source.

Ranked highest

1. Revenue Guidance and Outlook67 · importance in its document · 8-K exhibit · 5 Nov 2026
   Cardinal Health raised FY27 non-GAAP diluted EPS guidance to $12.80–$13.00 from $12.40–$12.60. The revised range represents 17%–19% growth from the FY26 ex-tariff-refund baseline and 14%–15% growth from reported FY26 results. The company…
2. Income Tax Rate Changes66 · importance in its document · 8-K exhibit · 5 Nov 2026
   The GAAP effective tax rate declined to 19.2% in Q1 FY27 from 24.1% in Q1 FY26, while income tax provision decreased 8% to $132 million from $144 million. The non-GAAP effective tax rate fell to 18.5% from 21.9%. Cardinal Health lowered…
3. Guidance raised60 · rule score among filings · 8-K Item 2.02 · 5 Nov 2026
   FOR IMMEDIATE RELEASE Cardinal Health Reports First Quarter Fiscal Year 2027 Results and Raises Outlook
4. Capital Allocation58 · importance in its document · 10-Q · 2026Q3
   During the three months ended September 30, 2026, Cardinal Health used $500 million for share repurchases, $157 million for capital expenditures, $149 million for acquisitions, and $126 million for dividends. The $500 million repurchase…
5. Acquisitions and Partnerships53 · importance in its document · 10-Q · 2026Q3
   On November 3, 2025, Cardinal Health completed its acquisition of Solaris Health, a urology managed services organization, through The Specialty Alliance for approximately $1.9 billion in cash, subject to adjustments. The preliminary…

Ranked by score, 0–100. A topic read from a document carries its importance within that document; an 8-K event carries the rule score that ranks a filing among filings. Neither is about the share price, and the two scales are named on each row because they are not the same measure.

Latest report: 10-Q · 2026Q3 filed 5 Nov 2026

Full report · Filing on EDGAR

• Capital AllocationImportance 58
  During the three months ended September 30, 2026, Cardinal Health used $500 million for share repurchases, $157 million for capital expenditures, $149 million for acquisitions, and $126 million for dividends. The $500…
• Acquisitions and PartnershipsImportance 53
  On November 3, 2025, Cardinal Health completed its acquisition of Solaris Health, a urology managed services organization, through The Specialty Alliance for approximately $1.9 billion in cash, subject to adjustments.…
• Pharmaceutical Specialty DemandImportance 49
  Cardinal Health’s Pharma segment revenue increased 6% year over year to $62.6 billion, primarily from branded and specialty pharmaceutical sales growth with existing customers. The company also experienced increased…
• IRS Tax DisputesImportance 46
  In June 2026, the IRS issued a Notice of Proposed Adjustment in Cardinal Health’s fiscal 2015–2020 audit concerning its captive insurance company and net operating loss carrybacks under the CARES Act. The IRS is…
• Opioid Litigation LiabilityImportance 44
  As of September 30, 2026, Cardinal Health had accrued $3.9 billion for opioid-related matters. It had paid the Settling Governmental Entities approximately $2.6 billion and expects to pay them up to an additional $3.7…
• Liquidity and Cash PositionImportance 43
  At September 30, 2026, cash and equivalents were $5.264 billion, up from $4.856 billion at June 30, 2026, while total long-term obligations, including current obligations and short-term borrowings, were $8.8 billion,…
• Gross Margin DriversImportance 42
  Gross margin increased 12% year over year to $2.596 billion in the three months ended September 30, 2026. The increase was primarily driven by the acquisition of MSO platforms, contributions from branded and specialty…
• Segment ProfitabilityImportance 41
  Pharmaceutical and Specialty Solutions segment profit increased 17% year over year to $783 million, reflecting increased contributions from branded and specialty pharmaceutical products and the generics program. Global…
• Pharmaceutical Pricing PolicyImportance 40
  The Inflation Reduction Act has capped prices for certain drugs and is expected to continue adversely affecting Cardinal Health’s revenue, although profitability has not been materially impacted. The Executive Order…
• Trade Policy and TariffsImportance 40 · +1 more on this subject
  An April 2026 U.S. presidential proclamation imposed tariffs on imported branded pharmaceuticals and associated ingredients; manufacturer price increases or stopped imports could raise costs or disrupt supply. From…
• Patient Recovery Tax DisputeImportance 40
  In February 2026, the IRS issued a Notice of Proposed Adjustment related to the restructuring connected with Cardinal Health’s July 2017 acquisition of the Patient Recovery business. The IRS asserts that the…
• Revenue Performance and MixImportance 36 · +1 more on this subject
  For the three months ended September 30, 2026, total revenue increased 5.5% to $67,513 million from $64,009 million a year earlier, a $3,504 million increase. Pharmaceutical and Specialty Solutions revenue rose 5.7% to…

8-K filings last 12 months

• Guidance raised5 Nov 2026 · 8-K Item 2.02 · Flagged · rule score 60
  “FOR IMMEDIATE RELEASE Cardinal Health Reports First Quarter Fiscal Year 2027 Results and Raises Outlook”
  Read from the attached exhibit: Revenue Guidance and Outlook · Income Tax Rate Changes · Acquisition / Partnership / Divestiture
• Press release attached to an 8-K1 Oct 2026 · 8-K
  Read from the attached exhibit: Guidance / Outlook · Customer Distribution Agreement · Customer Dynamics
• Results (release not read)11 Aug 2026 · 8-K Item 2.02 · Routine · rule score 20
• New debt11 Aug 2026 · 8-K Items 1.01, 2.03 · Routine · rule score 25
• Management change (filing not read)5 Aug 2026 · 8-K Item 5.02 · Routine · rule score 20
• Results (release not read)30 Apr 2026 · 8-K Item 2.02 · Routine · rule score 20
• Management change (filing not read)23 Mar 2026 · 8-K Item 5.02 · Routine · rule score 20
• Management change (filing not read)5 Mar 2026 · 8-K Item 5.02 · Routine · rule score 20
• Results (release not read)5 Feb 2026 · 8-K Item 2.02 · Routine · rule score 20

Topics are read from the text of the 10-K, 10-Q or the exhibit attached to an 8-K, each linked to the passage it came from. 8-K events are labelled by fixed rules from the item codes and the filing text — the same rules for every company and every year. The Full Picture merges these with earnings calls and news.